Free shipping on all orders over $ 500

E6446

Cat. No. M11308

All AbMole products are for research use only, cannot be used for human consumption.

E6446 Structure
Synonym:

E-6446

Size Price Availability Quantity
1mg USD 115  USD115 In stock
5mg USD 190  USD190 In stock
10mg USD 300  USD300 In stock
25mg USD 495  USD495 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

E6446 is an inhibitor of Toll-like receptor (TLR) 7 and 9 signaling in a variety of human and mouse cell types and inhibits DNA-TLR9 interactions in vitro. E6446 is also a potent SCD1 inhibitor (KD: 4.61 μM), significantly inhibiting adipogenic differentiation and hepatic lipogenesis through SCD1-ATF3 signaling.

E6446 (20, 60 mg/kg, p.o.) dose-dependently inhibits TLR9 signaling in mice. E6446 (60, 120 mg/kg, p.o.) prevents hyperresponsiveness of TLRs and LPS-induced septic shock in rodent malaria, diminishes TLR responsiveness during acute malaria, suppresses activation of both TLR7 and TLR9.

Chemical Information
Molecular Weight 449.59
Formula C27H35N3O3
CAS Number 1219925-73-1
Solubility (25°C) DMSO 5 mg/mL
Ethanol 45 mg/mL
Storage 2-8°C, dry, sealed
References

[1] Tomohito Ishikawa, et al. J Am Heart Assoc. Chronic Inhibition of Toll-Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats

[2] Hiromichi Ueda, et al. JACC Basic Transl Sci. Administration of a TLR9 Inhibitor Attenuates the Development and Progression of Heart Failure in Mice

[3] Keimei Yoshida, et al. Cardiovasc Res. Inhibition of TLR9-NF-κB-mediated sterile inflammation improves pressure overload-induced right ventricular dysfunction in rats

[4] Glenn D Bell, et al. PLoS One. mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446

[5] Bernardo S Franklin, et al. Proc Natl Acad Sci U S A. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria

Related TLR Products
Pepinh-TRIF TFA

Pepinh-TRIF TFA blocks TIR-domain-containing adapter-inducing interferon-β (TRIF) signaling by interfering with TLR-TRIF interaction.

CAY10614

CAY10614 is a potent TLR4 antagonist. CAY10614 inhibits the lipid A-induced activation of TLR4, with an IC50 of 1.675 μM.

TLR4-IN-C34-C2-COOH

TLR4-IN-C34-C2-COO is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis.

BNT411 

BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro.

Rabeximod

Rabeximod (ROB-803), an anti-rheumatic compound, impairs the differentiation and function of human pro-inflammatory dendritic cells and macrophages via downregulating TLR2 and TLR4 stimulation.

  Catalog
Abmole Inhibitor Catalog




Keywords: E6446, E-6446 supplier, TLR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.